It is generally believed that high CD8+ T-cells are associated with better prognosis and that tumor-associated macrophages (TAMs) and regulatory T-cells (FOXP3+) are associated with worse survival in uterine cancer, but study conclusions vary [14,15,16,17]. This evidence concerns the gene FOXP3 and neoplasm.